These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression. Yang Q, Titus MA, Fung KM, Lin HK. J Cell Biochem; 2008 Aug 01; 104(5):1612-24. PubMed ID: 18320593 [Abstract] [Full Text] [Related]
7. Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells. Altuwaijri S, Lin HK, Chuang KH, Lin WJ, Yeh S, Hanchett LA, Rahman MM, Kang HY, Tsai MY, Zhang Y, Yang L, Chang C. Cancer Res; 2003 Nov 01; 63(21):7106-12. PubMed ID: 14612503 [Abstract] [Full Text] [Related]
8. Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells. Bhuiyan MM, Li Y, Banerjee S, Ahmed F, Wang Z, Ali S, Sarkar FH. Cancer Res; 2006 Oct 15; 66(20):10064-72. PubMed ID: 17047070 [Abstract] [Full Text] [Related]
9. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms. Tepper CG, Vinall RL, Wee CB, Xue L, Shi XB, Burich R, Mack PC, de Vere White RW. Prostate; 2007 Apr 01; 67(5):521-35. PubMed ID: 17252539 [Abstract] [Full Text] [Related]
10. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells. Weiss-Messer E, Merom O, Adi A, Karry R, Bidosee M, Ber R, Kaploun A, Stein A, Barkey RJ. Mol Cell Endocrinol; 2004 May 31; 220(1-2):109-23. PubMed ID: 15196705 [Abstract] [Full Text] [Related]
11. A novel synthetic compound that interrupts androgen receptor signaling in human prostate cancer cells. Lu S, Wang A, Lu S, Dong Z. Mol Cancer Ther; 2007 Jul 31; 6(7):2057-64. PubMed ID: 17620434 [Abstract] [Full Text] [Related]
12. SRJ23, a new semisynthetic andrographolide derivative: in vitro growth inhibition and mechanisms of cell cycle arrest and apoptosis in prostate cancer cells. Wong HC, Wong CC, Sagineedu SR, Loke SC, Lajis NH, Stanslas J. Cell Biol Toxicol; 2014 Oct 31; 30(5):269-88. PubMed ID: 25070834 [Abstract] [Full Text] [Related]
14. Combination of resveratrol and antiandrogen flutamide has synergistic effect on androgen receptor inhibition in prostate cancer cells. Kai L, Levenson AS. Anticancer Res; 2011 Oct 31; 31(10):3323-30. PubMed ID: 21965742 [Abstract] [Full Text] [Related]
15. An AKT activity threshold regulates androgen-dependent and androgen-independent PSA expression in prostate cancer cell lines. Paliouras M, Diamandis EP. Biol Chem; 2008 Jun 31; 389(6):773-80. PubMed ID: 18627304 [Abstract] [Full Text] [Related]
18. Attenuation of androgenic regulation by brefeldin A in androgen-responsive prostate cancer cells. Alexander B, Fishman AI, Green D, Choudhury MS, Konno S. Urol Oncol; 2013 Jan 31; 31(1):104-9. PubMed ID: 21795077 [Abstract] [Full Text] [Related]